SCHEMBL25080

SCHEMBL25080

O=S(=O)(c1cccs1)N1CCN(c2ccc(C(O)(CF)C(F)F)cc2)[C@@H](Cn2ccc3cccnc32)C1

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 14/20 0.52
GCK P35557 6/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23692 0.91 GCKR (0.52) GCKRGCK
SCHEMBL12089991 0.88 GCK (0.56) GCKRGCK
SCHEMBL18463 0.87 GCK (0.67) GCKRGCK
SCHEMBL23232 0.87 GCK (0.67) GCKRGCK
SCHEMBL16801 0.87 GCK (0.67) GCKRGCK
SCHEMBL23231 0.87 GCK (0.67) GCKRGCK
SCHEMBL18317 0.85 GCKR (0.53) GCKRGCK
SCHEMBL26277 0.85 GCKR (0.56) GCKRGCK
SCHEMBL16197 0.83 GCKR (0.62) GCKRGCK
SCHEMBL16425 0.83 GCKR (0.62) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed